Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

IMSGC and MultipleMS project MS patients from Austria

ABSTRACT: Genotype and phenotype data on 246 MS patients from Austria. All individuals were whole-genome genotyped on the Illumina Global Screening Array and files are provided in plink2 format (pgen / pvar / psam files). Provided phenotypes are sex, year of birth, age and Age Related Multiple Sclerosis Severity (ARMSS) score.

PROVIDER: EGAD00010002487 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

IMSGC and MultipleMS project MS patients from Norway

Project description:Genotype and phenotype data on 575 MS patients from Netherlands. All individuals were whole-genome genotyped on the Illumina Global Screening Array and files are provided in plink2 format (pgen / pvar / psam files). Provided phenotypes are sex, year of birth, age and Age Related Multiple Sclerosis Severity (ARMSS) score.

| EGAD00010002485 | EGA

IMSGC and MultipleMS project MS patients from Spain

Project description:Genotype and phenotype data on 151 MS patients from Spain. All individuals were whole-genome genotyped on the Illumina Global Screening Array and files are provided in plink2 format (pgen / pvar / psam files). Provided phenotypes are sex, year of birth, age and Age Related Multiple Sclerosis Severity (ARMSS) score.

| EGAD00010002492 | EGA

IMSGC and MultipleMS project MS patients from UK

Project description:Genotype and phenotype data on 943 MS patients from UK. All individuals were whole-genome genotyped on the Illumina Global Screening Array and files are provided in plink2 format (pgen / pvar / psam files). Provided phenotypes are sex, year of birth, age and Age Related Multiple Sclerosis Severity (ARMSS) score.

| EGAD00010002491 | EGA

IMSGC and MultipleMS project MS patients from Netherlands

Project description:Genotype and phenotype data on 209 MS patients from Netherlands. All individuals were whole-genome genotyped on the Illumina Global Screening Array and files are provided in plink2 format (pgen / pvar / psam files). Provided phenotypes are sex, year of birth, age and Age Related Multiple Sclerosis Severity (ARMSS) score.

| EGAD00010002488 | EGA

IMSGC and MultipleMS project MS patients from Greece

Project description:Genotype and phenotype data on 140 MS patients from Greece. All individuals were whole-genome genotyped on the Illumina Global Screening Array and files are provided in plink2 format (pgen / pvar / psam files). Provided phenotypes are sex, year of birth, age and Age Related Multiple Sclerosis Severity (ARMSS) score.

| EGAD00010002493 | EGA

IMSGC and MultipleMS project MS patients from Italy, Piedmont

Project description:Genotype and phenotype data on 1067 MS patients from Italy, Piedmont. All individuals were whole-genome genotyped on the Illumina Global Screening Array and files are provided in plink2 format (pgen / pvar / psam files). Provided phenotypes are sex, year of birth, age and Age Related Multiple Sclerosis Severity (ARMSS) score.

| EGAD00010002490 | EGA

IMSGC and MultipleMS project MS patients from Germany, TUM

Project description:Genotype and phenotype data on 683 MS patients from Germany, TUM. All individuals were whole-genome genotyped on the Illumina Global Screening Array and files are provided in plink2 format (pgen / pvar / psam files). Provided phenotypes are sex, year of birth, age and Age Related Multiple Sclerosis Severity (ARMSS) score.

| EGAD00010002489 | EGA

IMSGC and MultipleMS project MS patients from Germany, Mainz

Project description:Genotype and phenotype data on 301 MS patients from Germany, Mainz. All individuals were whole-genome genotyped on the Illumina Global Screening Array and files are provided in plink2 format (pgen / pvar / psam files). Provided phenotypes are sex, year of birth, age and Age Related Multiple Sclerosis Severity (ARMSS) score.

| EGAD00010002484 | EGA

IMSGC and MultipleMS project MS patients from Italy, OSR

Project description:Genotype and phenotype data on 538 MS patients from Italy, OSR. All individuals were whole-genome genotyped on the Illumina Global Screening Array and files are provided in plink2 format (pgen / pvar / psam files). Provided phenotypes are sex, year of birth, age and Age Related Multiple Sclerosis Severity (ARMSS) score.

| EGAD00010002486 | EGA

ATF3 Potentiates APR-246-Induced Ferroptosis in Sarcoma by Repressing SLC7A11 Expression

Project description:APR-246 (Eprenetapopt) is a clinical-stage small molecule compound, while recent studies suggest its potential involvement in ferroptosis, the precise mechanism and its effects in sarcomas remain unclear. This investigation constitutes the first endeavor to confirm in sarcoma cells that APR-246 induces ferroptosis in a dose-responsive manner, characterized by elevated reactive oxygen species and lipid peroxidation, depletion of glutathione, and mitochondrial shrinkage. Furthermore, this effect can be reversed by ferroptosis inhibitors rather than apoptosis inhibitors. More importantly, This study uncovers that the transcription factor ATF3 serves a pivotal function as a sensitizer for APR-246-induced ferroptosis. Transcriptomic analysis reveals ATF3 as one of the most prominently upregulated genes post-APR-246 treatment. Functionally, ATF3 overexpression significantly lowers the half-maximal inhibitory concentration of APR-246, intensifying ferroptosis-related biochemical and ultrastructural impairments. Mechanistically, ATF3 inhibits the expression of SLC7A11 directly, impeding the compensatory antioxidant response induced by APR-246. Within the nude mouse xenograft models, ATF3 overexpression combined with APR-246 markedly boosts the anti-tumor efficacy without notable toxicity. Consequently, this investigation clarifies the anti-tumor mechanism of APR-246 in sarcomas via ferroptosis and proposes, for the first time, that the ATF3-SLC7A11 axis can serve as an intervention target to enhance its ferroptosis efficacy.

2026-05-26 | GSE329040 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data